MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
MRM’s platform could optimise the link between the gut microbiome and cancer outcomes
Read Moreby Esme Needham | Dec 18, 2025 | News | 0
MRM’s platform could optimise the link between the gut microbiome and cancer outcomes
Read Moreby Emily Kimber | Jun 23, 2025 | News | 0
The pilot will see GP practices look at patient records to identify those most at risk
Read Moreby Emily Kimber | Jun 18, 2025 | News | 0
The candidate is being evaluated as both a monotherapy and in combination pembrolizumab
Read MoreThe alliance combines Lumanity’s commercial and development strategy capabilities with PICI’s translational research expertise
Read MoreThe model could lead to more targeted treatments for the disease
Read Moreby Emily Kimber | Oct 22, 2024 | News | 0
The company’s workforce will volunteer and fundraise for Team Jak throughout the year
Read Moreby PharmaTimes | Aug 28, 2024 | News | 0
The partnership will improve care for patients with pancreatic cancer
Read Moreby PharmaTimes | Aug 27, 2024 | News | 0
Over 135,000 people have signed a petition to prioritise a national screening programme
Read Moreby PharmaTimes | Aug 23, 2024 | News | 0
Most cases go undetected until an advanced stage, as the disease rarely causes early symptoms
Read Moreby PharmaTimes | Aug 19, 2024 | News | 0
In the UK study, researchers analysed 2,023 bowel cancers from the 100,000 Genomes Project
Read Moreby Jen Brogan | Aug 16, 2024 | News | 0
This form of cancer was responsible for 1.9 million diagnosed cases worldwide in 2020
Read Moreby Jen Brogan | Aug 12, 2024 | News | 0
Bowel cancer was the most common cancer to be identified in both men and women
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
